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A b s t r a c t
Background: Myocardial infarction with non-obstructive coronary arteries (MINOCA) occurs more often in women. 
Aim: We sought to assess the relationship between sex and clinical outcomes during follow-up in patients after MINOCA and 
to identify predictors of major adverse cardiac and cerebrovascular events (MACCE).
Methods: The study comprised 134 patients (78 women) at the mean age of 61.6 years, who were diagnosed with MINOCA at 
the Department of Cardiology between January 2015 and June 2018. The mean follow-up duration was 609.5 ± 412.2 days. Pri-
mary study endpoints were MACCE, which included all-cause death, myocardial infarction, reintervention, and cerebral 
stroke. Secondary endpoints were recurrent chest pain during follow-up and rehospitalisation for reasons other than MACCE.
Results: Kaplan-Meier survival curve analysis did not reveal any significant differences in the frequency of MACCE (p = 0.63) 
or mortality rate (p = 0.29) between men and women. There was no significant impact of sex on secondary study endpoints 
either. Sex was not identified as a predictor of primary or secondary study endpoints in univariate or multivariate analysis.  
Troponin index (risk ratio [RR] 1.002; 95% confidence interval [CI] 1.0005–1.0026, p = 0.004), age (RR 1.04; 95% CI 
1.008–1.065, p = 0.01), serum creatinine level (RR 1.01; 95% CI 1.001–1.01, p = 0.02), hyperlipidaemia (RR 0.26; 95% 
CI 0.07–0.75, p = 0.01), and prior venous thromboembolic disease (RR 8.28; 95% CI 1.15–38, p = 0.04) were found to be 
predictors of MACCE in multivariate analysis. 
Conclusions: Sex was not found to be significantly associated with clinical outcomes during the follow-up period in patients 
with MINOCA. 
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INTRODUCTION
Symptomatic coronary artery disease (CAD) presenting as 
chest pain does not always coexist with obstructive CAD. In 
some patients various forms of the disease (stable CAD or 
acute coronary syndrome) coincide with non-obstructive 
CAD [1, 2]. Several mechanisms have been found to be 
responsible for different clinical presentation of CAD in 
those patients. In patients with myocardial infarction with 
non-obstructive coronary arteries (MINOCA), the aetiology 
of the disease is very heterogeneous, and atherosclerosis is 
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not the most prevalent cause, in contrast to patients with 
typical risk factors for atherosclerosis or those with myocardial 
infarction (MI) with obstructive CAD. In a large proportion 
(up to 25%) of patients with MINOCA, the aetiology is linked 
to hypercoagulable states. This especially concerns women 
who, in many of the published studies, make up the vast 
majority the population and in whom blood clotting disorders 
may be due to menopause, pregnancy, or childbirth [2, 3]. 
Recently published studies performed in patients with 
ST-segment elevation myocardial infarction (STEMI) and 
MINOCA diagnosed with intravascular ultrasound increased 
the significance of coronary atherosclerotic lesions, which are 
often assessed as mild via regular coronary angiography [4]. 
It was also shown that plaque burden was the most powerful 
predictor of future acute coronary events [5]. Large registry 
studies revealed that the incidence of MINOCA is higher in 
women compared to men and that MINOCA patients more 
often present with non-ST-segment elevation myocardial 
infarction (NSTEMI) than STEMI [6]. 
The aim of the current study was to assess the relation-
ship between sex and clinical outcomes during follow-up in 
patients after MINOCA and to identify predictors of major 
adverse cardiac and cerebrovascular events (MACCE) in 
this group.
METHODS
We retrospectively analysed 1984 consecutive patients ad-
mitted to our catheterisation laboratory and to our Depart-
ment of Cardiology due to MI from January 2015 until June 
2018. From this group we extracted 134 (6.75%) patients with 
MINOCA (56 [41.8%] men). Both MI and MINOCA were 
diagnosed according to the previous definition of MI [2, 3]. 
Due to the fact that the troponin level was estimated using 
different assays, we calculated the troponin index from the 
maximal troponin value measured during hospitalisation in 
order to unify the results. The troponin index was calculated 
by dividing the troponin concentration by the upper limit of 
the reference range for the particular assay. Glomerular filtra-
tion rate (GFR) was estimated according to the Cockroft-Gault 
formula. Kidney failure was diagnosed when the GFR level 
was lower than 60 mL/min. Coronary slow-flow phenomenon 
was diagnosed on the basis of grade 2 on the Thrombolysis in 
Myocardial Infarction (TIMI) scale [7]. Slow flow was assumed 
as an indirect indicator of microcirculatory dysfunction. 
This study complies with the Declaration of Helsinki. 
All subjects gave informed consent to participate before the 
investigation began.
Study endpoints
This was an observational follow-up study. Primary endpoints 
were main MACCE, which included cerebral stroke, MI, 
death, percutaneous coronary reintervention, and coronary 
artery bypass grafting. Secondary study endpoints were recur-
rent chest pain as well as rehospitalisation for reasons other 
than MACCE, such as anaemia, gastrointestinal bleedings, 
infections (e.g. pneumonia), and any other conditions that 
could possibly lead to the onset of type 2 MI. Data regard-
ing primary and secondary endpoints were obtained on the 
basis of medical records gathered during follow-up visits at 
the outpatient clinic or by telephone. 
Statistical analysis 
Continuous variables are expressed as means and standard 
deviations or median and interquartile range, and categori-
cal variables are shown as numbers and percentages. The 
investigated groups were analysed using the Shapiro-Wilk 
test to assess continuous data distribution. We compared 
men and women with the Mann-Whitney U-test, Student t 
test, Welch’s t test, Person’s c2 test, Fisher’s exact test, and 
the Cochrane-Armitage test for trends when appropriate. 
Kaplan-Meier analysis was used for primary endpoint assess-
ment. Mantel-Cox analysis was used for comparison between 
Kaplan-Meier survival curves for death and MACCE. In order 
to identify factors influencing the primary study endpoints, 
univariate and multivariate Cox regression proportional hazard 
models were constructed. Univariate Cox regression analysis 
was also adjusted for sex. To identify factors influencing sec-
ondary study endpoints, logistic regression analysis was per-
formed along with adjustment for sex. Statistical significance 
was accepted at a p-value of 0.05. The statistical analyses were 
performed using the Statistica 10.0 software (Dell Software, 
Inc., Round Rock, TX, USA) and the SPSS STATISTICS 24 (IBM, 
SPSS Inc., Chicago, IL, USA).
RESULTS
Epidemiology, frequency,  
and aetiology of MINOCA
The overall frequency of MINOCA among all the patients ad-
mitted to our department was estimated at 6.75% and it was 
higher in women than in men (11.3% vs. 4.7%, p < 0.001) 
(Fig. 1). On admission, 104 (77.6%) patients with MINOCA 
were diagnosed with NSTEMI, whereas 30 (22.4%) patients 
had STEMI. Upon discharge from hospital, 68 (50.7%) pa-
tients were diagnosed with NSTEMI, 11 (8.2%) had myocar-
ditis, 17 (12.7%) had takotsubo cardiomyopathy, five (3.7%) 
had tachyarrhythmia, 12 (8.9%) had STEMI, there were six 
(4.5%) cases of heart failure, nine (6.7%) patients had type 2 
MI, two (1.5%) had hypertrophic cardiomyopathy, and 
there were single cases of thromboembolic disease, arterial 
hypertension, myocardial bridge, and cerebral stroke (0.7% 
of patients each). The following aetiologies of MINOCA 
were revealed: unknown aetiology in 50 (37.3%) patients, 
takotsubo cardiomyopathy in 20 (14.9%) patients, tachyar-
rhythmia in 16 (11.9%) patients, myocarditis in 11 (6.7%) 
patients, slow-flow phenomenon in nine (6.7%) patients, 
arterial hypertension in five (3.7%) patients, myocardial 
bridge in four (3%) patients, arterial spasm, hypertrophic 
cardiomyopathies, and tumour embolisations in three 
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(2.2%) patients each, anaemia in two (1.5%) patients, as 
well as atrioventricular block, aortic dissection, muscular 
dystrophy, cerebral stroke, alcohol-induced cardiomyopathy, 
aortic valve stenosis, and antiphospholipid syndrome in one 
(0.7%) patient each. 
General characteristics
In the group of patients included in the study, women 
were significantly older than men (66.6 ± 13.7 years 
vs. 56 ± 41.8 years, p < 0.001). The mean body mass index 
(BMI) was significantly lower in women compared to men 
(26.4 ± 5.8 kg/m2 vs. 28.1 ± 4.4 kg/m2, p = 0.02). Cardiac ar-
rest on admission occurred only in men (six cases, p = 0.002), 
whereas women, in comparison to men, more often suffered 
from hyperlipidaemia (24.5% vs. 42.3%, p = 0.03), hyperten-
sion (59.2% vs. 75.6%, p = 0.04), and chronic kidney failure 
(11.8% vs. 32.8%, p = 0.007) (Table 1).
Pharmacotherapy
Women with MINOCA were numerically more often treated 
with acetylsalicylic acid before admission to hospital, but 
without statistical significance (16% vs. 29.8%, p = 0.08). 
However, statins were significantly more often used in women 
compared to men (16% vs. 32.8%, p = 0.03) (Table 2). 
Biochemical indices
With regard to biochemical indices, there was a significantly 
greater mean value of troponin index in men compared 
to women (243.3 ± 302 vs. 167 ± 265.1, p = 0.03), 
whereas the mean N-terminal pro–B-type natriuretic pep-
tide (NT-proBNP) concentration was significantly higher 
in women (2671.0 [692.5–5102.0] pg/mL) than in men 
(485.6 [156.0–1393.3] pg/mL); p = 0.02. The mean hae-
moglobin concentration was significantly lower in women 
compared to men (12.5 ± 1.5 g/dL vs. 13.5 ± 2.2 g/dL, 
p < 0.001). The mean high-density lipoprotein choles-
terol concentration was higher in women compared to men 
(1.4 ± 0.4 mmol/L vs. 1.1 ± 0.3 mmol/L, p < 0.001), and 
the mean serum creatinine concentration was significantly 
greater in men (86.2 ± 37.4 mmol/L vs. 76 ± 42.8 mmol/L, 
p < 0.001). The mean GFR was significantly lower in women 
compared to men (83 ± 41 mL/min vs. 120 ± 52.3 mL/min, 
p < 0.001; Table 3). 
Electrocardiography, cardiac echocardiography, 
and coronary angiography 
There were no significant differences in electrocardiographic 
signs of myocardial ischaemia, except for the T-wave inversion, 
which occurred significantly more often in women compared 
to men (24.3% vs. 8.9%, p = 0.02). Also, echocardiographic 
parameters did not differ significantly between these two 
groups, despite the fact that there were numerically more 
female than male patients with impaired left ventricular ejec-
tion fraction (LVEF) below 40% (28.2% vs. 18.2%, p = 0.18), 
left ventricular akinesis (33.3% vs. 24.4%, p = 0.08), and 
pericardial effusion (11.7% vs. 5.9%, p = 0.26). Conversely, 
left ventricular hypertrophy tended to be observed more often 
in men compared to women (29.4% vs. 17.9%, p = 0.12). 
In terms of coronary angiography findings, there were 
numerically more cases of muscular bridges (12.5% vs. 5.1%, 
p = 0.12), arterial spasms (5.3% vs. 1.3%, p = 0.17), contrast 
slow-flows (19.6% vs. 14.1%, p = 0.39), and atherosclerotic 
Figure 1. The rate of myocardial infarction with non-obstructive coronary arteries diagnosed at the Cardiology Department of 
the University Hospital in Krakow in the years 2015–2018, according to sex and the type of myocardial infarction;  STEMI —  
ST-segment elevation myocardial infarction; NSTEMI — non-ST-segment elevation myocardial infarction
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plaques (85% vs. 71.8%, p = 0.11) in men compared to 
women, but without statistical significance (Table 4). 
Primary and secondary study endpoints 
The mean duration of the follow-up period was almost equal in 
men and women (609.5 ± 434.7 days vs. 609.5 ± 398.1 days, 
p = 0.99). The percentage of completed follow-ups (92.8% 
vs. 91%, p = 0.7) and MACCE rate (19.2% vs. 22.5%, 
p = 0.65) also did not differ significantly between these two 
groups. With regard to primary and secondary study end-
points, mortality was similar between the two groups  (18.6% 
vs. 11.5%, p = 0.3) (Table 5). 
Table 1. Clinical characteristics of MINOCA patients
Men (n = 56) Women (n = 78) p Overall (n = 134)
Age [years] 54.5 ± 17.4 66.6 ± 13.7 < 0.001 61.6 ± 16.4
BMI [kg/m2] 28.1 ± 4.4 26.4 ± 5.8 0.02 27.1 ± 5.3
Hospitalisation time [days] 6 ± 3.1 7.1 ± 3.5 0.055 6.7 ± 3.4
Second episode of MINOCA 5 (8.9) 7 (9.1) 0.97 12 (9)
Chest pain on admission 23 (44.2) 27 (34.6) 0.26 50 (38.5)
Cardiac arrest during MI 6 (11) 0 (0) 0.002 6 (4.5)
NSTEMI on admission 42 (75) 62 (79.5) 0.53 104 (77.6)
Diabetes 11 (20.4) 18 (23.1) 0.71 29 (22)
Hyperlipidaemia 13 (24.5) 33 (42.3) 0.03 46 (35.1)
Hypertension 32 (59.2) 59 (75.6) 0.04 91 (68.9)
Smoking 19 (35.2) 17 (22.1) 0.09 36 (27.5)
COPD/Bronchial asthma 3 (5.5) 7 (9) 0.46 10 (7.6)
Chronic kidney failure 6 (11.8) 22 (32.8) 0.007 28 (23.7)
Venous thromboembolic disease 1 (1.8) 0 (0) 0.23 1 (0.8)
Prior MI 7 (12.7) 13 (16.7) 0.53 20 (15)
Prior PCI 7 (12.7) 7 (9) 0.48 14 (10.5)
Prior TIA/cerebral stroke 1 (1.9) 7 (9) 0.08 8 (6)
Pacemaker/ICD/CRT 1 (1.9) 4 (5.2) 0.31 5 (3.8)
Autoimmune diseases 2 (3.8) 2 (2.6) 0.71 4 (3.1)
Cancer 1 (1.9) 2 (2.7) 0.77 3 (2.3)
Alcohol abuse 2 (3.8) 1 (1.4) 0.38 3 (2.4)
Data are presented as arithmetic mean ± standard deviation or number (percentage). BMI — body mass index; COPD — chronic obstructive 
pulmonary disease; CRT — cardiac resynchronisation therapy; ICD — implantable cardioverter-defibrillator; MI — myocardial infarction;  
MINOCA — myocardial infarction with non-obstructive coronary artery; NSTEMI — non-ST-segment elevation myocardial infarction;  
PCI — percutaneous coronary intervention; TIA — transient ischaemic attack
Table 2. Pharmacotherapy before admission to hospital
Men Women P Overall
Acetylsalicylic acid 8 (16) 20 (29.8) 0.08 28 (23.9)
Anticoagulant 6 (12.2) 8 (11.9) 0.96 14 (12.1)
Statin 8 (16) 22 (32.8) 0.03 30 (25.6)
DAPT 3 (6) 3 (4.4) 0.69 6 (5.1)
b-blocker 11 (22) 23 (34.3) 0.14 34 (29)
Glucocorticosteroids 1 (2) 4 (5.9) 0.3 5 (4.2)
Hormonal contraception 0 (0) 1 (1.4) 0.38 1 (0.8)
HRT 0 (0) 1 (1.4) 0.38 1 (0.8)
Amphetamine 2 (3.6) 0 (0) 0.09 2 (1.5)
Data are presented as numbers (percentages). DAPT — dual antiplatelet therapy; HRT — hormone replacement therapy
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Table 3. Biochemical parameters
Men Women P Overall
Maximum troponin index 243.3 ± 302 167 ± 265.1 0.03 198.8 ± 282.5
CK-MB on admission [IU/L] 50.2 ± 100.4 34.6 ± 36.4 0.12 41 ± 70.1
Maximum CK-MB [IU/L] 78.9 ± 253.3 39.4 ± 39.9 0.1 56.1 ± 167.5
Elevated C-reactive protein (> ULN) 27 (75) 35 (85.3) 0.25 60 (77)
C-reactive protein [mg/L] 33.6 ± 51.5 36.6 ± 41.1 0.99 35.3 ± 45.5
NT-proBNP [pg/mL] 485.6 [156.0–1393.3] 2671.0 [692.5–5102.0] 0.02 4170 ± 6779
D-dimer [mg/L] 3.73 ± 6.4 1.74 ± 5.64 0.6 2.49 ± 6
Leucocytes [×103/mL] 8.7 ± 2.6 9.6 ± 3.6 0.24 9.23 ± 3.3
Haemoglobin [g/dL] 13.5 ± 2.2 12.5 ± 1.5 < 0.001 12.9 ± 1.9
Platelet count [×103/mL] 205.3 ± 54.1 217.1 ± 73.4 0.37 221.3 ± 66.1
Total cholesterol [mmol/L] 4.5 ± 1 4.9 ± 1.2 0.08 4.74 ± 1.1
HDL-C [mmol/L] 1.1 ± 0.3 1.4 ± 0.4 < 0.001 1.3 ± 0.4
LDL-C [mmol/L] 2.7 ± 1 2.8 ± 1.1 0.62 2.8 ± 1.1
Triglycerides [mmol/L] 1.5 ± 0.8 1.4 ± 0.6 0.65 1.5 ± 0.7
Creatinine [mmol/L] 86.2 ± 37.4 76 ± 42.8 < 0.001 80.2 ± 40.8
GFR [mL/min] 120 ± 52.3 83 ± 41 < 0.001 99.4 ± 49.7
Data are presented as arithmetic mean ± standard deviation or median [interquartile range], or number (percentage); CK-MB — creatine kinase-MB; 
GFR — glomerular filtration rate; HDL-C— high-density lipoprotein cholesterol; LDL-C — low-density lipoprotein cholesterol; NT-proBNP — N-terminal 
pro–B-type natriuretic peptide; ULN — upper limit of normal 
Table 4. Electrocardiography, cardiac echocardiography, and coronary angiography
Men Women P Overall
Electrocardiography on admission:
ST-segment elevation 14 (25) 15 (19.2) 0.42 29 (21.6)
ST-segment depression 8 (14.3) 15 (19.2) 0.45 23 (17.2)
T-wave changes 5 (8.9) 19 (24.3) 0.02 24 (17.9)
Other* 29 (51.8) 29 (37.2) 0.09 58 (43.3)
Echocardiography on admission:
LVEF [%] 51.7 ± 15.7 50.3 ± 14.1 0.38 50.9 ± 14.7
LVEF < 40% 10 (18.2) 22 (28.2) 0.18 32 (24.1)
Wall motion disorders on admission: 34 (66.7) 60 (76.9) 0.2 94 (72.9)
Hypokinesis 24 (58.5) 34 (43.6) 0.69 58 (45)
Akinesis 10 (24.4) 26 (33.3) 0.08 36 (27.9)
Pericardial effusion 3 (5.9) 9 (11.7) 0.26 12 (9.4)
Left ventricular hypertrophy 15 (29.4) 14 (17.9) 0.12 29 (22.5)
Coronary angiography
Plaques (> 0% stenosis < 50%) 34 (85) 56 (71.8) 0.11 90 (76.3)
Bridges 7 (12.5) 4 (5.1) 0.12 11 (8.2)
Arterial spasm 3 (5.3) 1 (1.3) 0.17 4 (3)
Contrast slow-flow 11 (19.6) 11 (14.1) 0.39 22 (16.4)
Data are presented as arithmetic mean ± standard deviation or number (percentage). LVEF — left ventricular ejection fraction; 
*e.g. tachyarrhytmias/bradyarrhytmias, atrial fibrillation/flagellation, repolarisation disorders, conduction disorders
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Kaplan-Meier survival curves according to sex
Due to the low number of particular components of MACCE, 
except for death, which was the leading component, we lim-
ited the analysis to MACCE and death. The analysis of MACCE 
survival curves during the follow-up period revealed no signifi-
cant differences between men and women (p = 0.63). How-
ever, the occurrence of MACCE tended to be higher in women 
compared to men (Fig. 2A, Table 5). The analysis of death sur-
vival curves during the follow-up period also did not demon-
strate any significant difference between the sexes (p = 0.29). 
The frequency of deaths tended to be higher in women 
(Fig. 2B, Table 5).
Predictors of MACCE and death 
Again, due to the low number of particular MACCE compo-
nents, except for death, only the predictors of MACCE and 
death were analysed.
Univariate Cox regression analysis identified the following 
variables as predictors of death during the follow-up: chest 
pain on admission to hospital (hazard ratio [HR] 0.21; 95% 
confidence interval [CI] 0.03–0.7, p = 0.01), treatment with 
glucocorticosteroids (GCSs) (HR 14.2; 95% CI 4.29–43.05, 
p = 0.0001), smoking (HR 0.13; 95% CI 0.008–0.677, 
p = 0.009), pericardial effusion (HR 4.13; 95% CI 1.15–11.8, 
p = 0.03), serum C-reactive protein (CRP) level below upper 
Figure 2. A. Kaplan-Meier survival curves according to sex — days to major adverse cardiac and cerebrovascular events (MACCE) 
for male grouping variable. The log rank test p-value = 0.63; B. Kaplan-Meier survival curves according to sex — days to death 
for male grouping variable. The log rank test p-value = 0.29
Table 5. Primary and secondary study endpoints according to sex
Men Women P Overall
Follow-up time [days] 609.5 ± 434.7 609.5 ± 398.1 0.99 609.5 ± 412.2
Completed follow-up 52 (92.8) 71 (91) 0.7 123 (91.8)
MACCE 10 (19.2) 16 (22.5) 0.65 26 (21.1)
Myocardial infarction 2 (3.8) 1 (1.4) 0.38 3 (2.4)
Cerebral stroke 1 (1.9) 0 (0) 0.24 1 (0.8)
CABG 0 (0) 0 (0) - 0 (0)
Death 6 (11.5) 13 (18.6) 0.3 19 (15.4)
Reintervention 1 (1.9) 2 (2.8) 0.75 3 (2.4)
Recurrent chest pain 10 (19.6) 13 (18.8) 0.91  23 (19.2)
Rehospitalisation not related to MACCE 10 (19.6) 11 (15.9) 0.6 21 (17.5)
Data are presented as arithmetic mean ± standard deviation or number (percentage). CABG — coronary artery bypass grafting; MACCE — major 
adverse cardiac and cerebrovascular events
A B
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limit of normal (HR 0.000; 95% CI 0.00–0.63, p = 0.01), age 
(HR 1.8; 95% CI 1.26–2.7, p = 0.0007), BMI (HR 0.88; 95% 
CI 0.79–0.98, p = 0.02), serum creatinine level (HR 1.008; 
95% CI 1.001–1.012, p = 0.02), GFR (HR 0.97; 95% CI 
0.95–0.98, p < 0.001), LVEF (HR 0.96; 95% CI 0.94–0.99, 
p = 0.03), troponin index (HR 1.002; 95% CI 1.001–1.003, 
p = 0.004), creatine kinase-MB (CK-MB) on admission 
to hospital (HR 1.006; 95% CI 1.003–1.008, p = 0.002), 
maximal serum CK-MB (HR 1.002; 95% CI 1.001–1.003, 
p = 0.008), blood haemoglobin concentration (HR 0.665; 
95% CI 0.53–0.82, p < 0.001), white blood cell count (HR 
1.19; 95% CI 1.06–1.33, p = 0.003), total cholesterol level 
(HR 0.49; 95% CI 0.25–0.97, p = 0.04), and low-density 
lipoprotein cholesterol (LDL-C) level (HR 0.44; 95% CI 
0.18–0.97, p = 0.04). 
After adjustment for male sex, the following predictors 
remained significant: chest pain on admission, cardiac arrest 
on admission, treatment with GCSs, smoking, pleural effusion, 
CRP level on admission below upper limit of normal, age, serum 
creatinine concentration, GFR level, LVEF value, troponin index, 
CK-MB on admission, maximal CK-MB, haemoglobin concen-
tration, and leucocyte count. Proportional hazard multivariate 
analysis confirmed that leucocyte count (risk ratio [RR] 1.23; 
95% CI 1.08–1.4, p = 0.002), platelet count (RR 0.99; 95% 
CI 0.98–0.99, p = 0.02), troponin index (RR 1.001; 95% CI 
1.0001–1.002, p = 0.029), blood haemoglobin concentration 
(RR 0.74; 95% CI 0.55–0.98, p = 0.03), ST-segment depres-
sions on admission to hospital (RR 2.96; 95% CI 1.05–8.88, 
p = 0.04), and hyperlipidaemia (RR 0.06; 95% CI 0.01–0.27, 
p < 0.0001) were independent predictors of death.
Univariate Cox regression analysis revealed that predic-
tors of MACCE during the follow-up included the following: 
cardiac arrest on admission to hospital (HR 6.84; 95% CI 
1.58–20.7, p = 0.01), treatment with GCSs (HR 9.01; 95% 
CI 2.88–24.01, p = 0.0006), smoking (HR 0.3; 95% CI 0.07– 
–0.87, p = 0.02), age (HR 1.42; 95% CI 1.08–1.93, p = 0.01), 
BMI (HR 0.91; 95% CI 0.84–0.99, p = 0.04), serum creatinine 
concentration (HR 1.006; 95% CI 1.000–1.011; p = 0.04), 
GFR (HR 0.98; 95% CI 0.97–0.99; p = 0.002), troponin index 
(HR 1.002; 95% CI 1.001–1.002, p = 0.006), CK-MB level 
on admission to hospital (HR 1.006; 95% CI 1.002–1.008, 
p = 0.002), maximal CK-MB level (HR 1.002; 95% CI 
1.001–1.003, p = 0.01), blood haemoglobin concentration 
(HR 0.77; 95% CI 0.63–0.94, p = 0.01), leucocyte count (HR 
1.16; 95% CI 1.05–1.28, p = 0.007), total serum cholesterol 
concentration (HR 0.57; 95% CI 0.34–0.97, p = 0.04), and 
LDL-C level (HR 0.42; 95% CI 0.21–0.78, p = 0.006). After 
adjustment for male sex, the following predictors remained 
significant: cardiac arrest on admission, treatment with GCSs, 
age, GFR value, troponin index, CK-MB level on admission 
to hospital, maximal CK-MB level, blood haemoglobin con-
centration, leucocyte count, and LDL-C level. Proportional 
hazard multivariate analysis confirmed the following to be 
independent predictors of MACCE: troponin index (RR 1.002; 
95% CI 1.0005–1.0026, p = 0.004), age (RR 1.04; 95% CI 
1.008–1.065, p = 0.01), serum creatinine level (RR 1.01; 95% 
CI 1.001–1.01, p = 0.02), hyperlipidaemia (RR 0.26; 95% 
CI 0.07–0.75, p = 0.01) and prior venous thromboembolic 
disease (RR 8.28; 95% CI 1.15–38, p = 0.04). 
Predictors of chest pain and rehospitalisation
Univariate logistic regression analysis revealed the following 
to be among the predictors of recurrent chest pain during the 
follow-up period: chest pain on admission to hospital (odds 
ratio [OR] 2.77; 95% CI 1.08–7.08, p = 0.03), hyperlipidae-
mia (OR 2.95; 95% CI 1.17–7.41, p = 0.02), treatment with 
acetylsalicylic acid (OR 4.38; 95% CI 1.59–12.2, p = 0.005), 
treatment with statins (OR 2.96; 95% CI 1.08–8.08, p = 0.04), 
troponin index at baseline (OR 0.99; 95% CI 0.99–1.00, 
p = 0.008), CK-MB level on admission to hospital (OR 0.97, 
95% CI 0.95–1.005, p = 0.03), maximal CK-MB during hospi-
talisation (OR 0.97; 95% CI 0.94–1.002, p = 0.01), leucocyte 
count (OR 0.76; 95% CI 0.62–0.94, p = 0.003), and platelet 
count (OR 0.99; 95% CI 0.98–0.99, p = 0.02). After adjust-
ment for male sex, none of the predictors remained significant. 
Maximal CK-MB level during hospitalisation (OR 0.98; 
95% CI 0.94–1.00, p = 0.03) and NT-proBNP level (OR 1.02; 
95% CI 1.01–1.05, p = 0.005) were identified as predictors 
of rehospitalisation during follow-up in univariate logistic 
regression analysis. After adjustment for male sex, chest pain 
on admission, dual antiplatelet therapy, and left ventricular 
contractility disorders significantly correlated with rehospitali-
sation rate during the follow-up period. 
DISCUSSION
One of the main findings of the presented study was that 
the rate of MINOCA among the overall MI population in our 
centre was 6.75%, and it was significantly higher in women 
than in men. Secondly, the most common diagnosis, both 
on admission to hospital and at discharge, was NSTEMI, 
whereas STEMI was observed less often. The most common 
known aetiology of MINOCA was takotsubo cardiomyopathy, 
followed by tachyarrhythmias. Thirdly, the clinical outcomes 
during the follow-up period were not significantly different 
between men and women. Also, the rate of recurrent chest 
pain and rehospitalisation during follow-up did not differ 
between the sexes. 
According to current knowledge and recently published, 
large systematic reviews, the frequency of MINOCA is esti-
mated at 6% with 95% CI 5%–7% [8]. However, a higher 
incidence of MINOCA (over 11%) was shown in a group of 
younger patients aged 18 to 55 years, consisting mostly of 
women [3]. In one of the recent large review articles, the ratio 
of men to women with MINOCA was different or even inverse 
(40% women) compared to our study, in which the percent-
age of women reached almost 60% [8]. Nevertheless, some 
publications support our results and report a higher incidence 
of MINOCA in women compared to men [9]. Similarly to our 
www.kardiologiapolska.pl
Magdalena Jędrychowska et al.
204
analysis, the rate of MINOCA in a population-based registry 
study including patients with acute coronary syndromes 
without ST-segment elevation was more than twice as high 
in women as in men, although the overall rate of MINOCA 
was lower than reported herein (4.9%). Despite the fact that 
women included in our analysis were older and women 
included in the registry were more often hyperlipidaemic 
and former cigarette smokers, the frequency of diabetes and 
hypertension was comparable [10]. Similar findings have been 
confirmed in the analysis by Lansky et al. [11] performed in 
a group of patients with acute MI, in which women, despite 
being older and having more comorbid diseases, had less 
extensive CAD compared to men. Previously published studies 
revealed that the one-year mortality in MINOCA patients was 
4.75%, while in our study, after almost two years of follow-up, 
it reached 15.4% in the overall group of patients [8]. Also, 
in the analysis performed on a large Swedish registry, which 
included over 12,000 patients with MINOCA, mortality rate 
during 2.6-year follow-up was 8% in STEMI patients and 5% 
in NSTEMI patients, which was significantly lower compared 
to our results [12]. 
In comparison to our analysis, studies in which the aeti-
ology of MINOCA was determined based on magnetic reso-
nance imaging (MRI) demonstrated greater rates of myocarditis 
(33%), arterial spasms (27%), and thrombophilia (14%) [8]. 
We were not able to compare these results due to the fact 
that MRI and blood tests for thrombophilia were performed 
only in a few of the analysed patients [13]. Young patients 
with suspected thrombophilia were referred to an outpa-
tient clinic to be screened for hypercoagulable disorders. In 
the follow-up period, it turned out that almost none of the 
patients volunteered to perform the ordered tests. Therefore, 
it can be concluded that the most successful way to screen 
patients for this disease would be to perform the tests while 
they are at the clinic, although this is not recommended in 
the acute condition. Endovascular diagnostic tools, including 
optical coherence tomography and intravascular ultrasound 
(IVUS), were used in several patients. IVUS examination was 
performed in patients with suspected spontaneous coronary 
artery dissection and soft atherosclerotic plaque rupture. In 
the last year, the frequency of IVUS application significantly 
increased at our centre.
We did not observe significant differences in MACCE or 
death rate between men and women during the follow-up 
period; however, there was a tendency towards higher mor-
tality in women. Similar results have been demonstrated for 
stable patients with non-obstructive CAD. It was shown that 
mortality in NSTEMI patients was higher in men, while in 
STEMI patients there was no significant difference in mortality 
between the sexes [6]. In the current study, the mean age of 
women who died during the follow-up period was 70.1 years 
(range, 40 to 90 years), while among male non-survivors it was 
74.7 years (range, 51 to 90 years). This was significantly higher 
compared to patients who survived the follow-up period. Of 
the 19 patients who died in the follow-up period, four (21%) 
deaths occurred during hospitalisation. These patients were 
characterised by severe comorbidities such as sepsis, end-stage 
renal failure, cardiac tamponade in the course of hospitalisa-
tion, and the presence of sudden cardiac arrest on or before 
admission to hospital. However, the overall group of patients 
who died during the follow-up period was characterised by 
older age (p < 0.001), lower GFR value (p < 0.001), higher 
maximal CK-MB concentration (p < 0.01), lower haemoglo-
bin concentration (p < 0.001), higher white blood cell count 
(p = 0.03), and higher levels of D-dimer (p < 0.001). What is 
more, the incidence of comorbidities was also higher in this 
group. It has been demonstrated that most of the predictors of 
adverse cardiovascular events following MINOCA are similar 
to the predictors of adverse events after regular acute MI 
with obstructive CAD. The WISE study identified hyperten-
sion, diabetes, and smoking as predictors of cardiovascular 
death and MI in women with signs of heart ischaemia during 
long-term follow-up, while in the current study, multivariate 
analysis did not confirm these factors as predictors of MACCE 
or death. Instead, the predictors identified in multivariate 
analysis were troponin level, age, serum creatinine level, 
and history of thromboembolic disease for MACCE, as well 
as leucocyte and platelet count, serum troponin level, blood 
haemoglobin concentration, and ST-segment depressions on 
admission to hospital for death [14]. In the current analysis, 
the increase in troponin and CK-MB levels at index procedure 
were found to be predictors of clinical outcomes expressed 
as the rate of MACCE and death, and troponin elevation was 
also associated with the occurrence of chest pain during the 
follow-up period, while the CK-MB level was associated with 
the rehospitalisation rate. The relationship between the extent 
of increase in markers of myocardial injury among patients 
with MINOCA and clinical outcomes expressed as the rate 
of MACE, all-cause mortality, cardiovascular mortality, and 
readmissions for heart failure during the follow-up period has 
been demonstrated in previously published studies [15]. How-
ever, the knowledge about the predictors of recurrent chest 
pains after MINOCA is smaller. It has been demonstrated that 
persistent chest pain after MINOCA is a predictor of adverse 
cardiovascular events [8]. Due to that reason and because of 
the unquestionable deterioration in quality of life that occurs 
after hospital discharge, we tried to identify potential predic-
tors of recurrent chest pain on the basis of the information 
gathered during follow-up. 
Available publications concerning the assessment of pre-
dictors of clinical outcomes after MINOCA are often based 
on large registries and do not include all biochemical data. 
Previously published studies, apart from the well-known pre-
dictors of MACCE such as older age, diabetes, hypertension, 
smoking, prior MI or cerebral stroke, chronic obstructive pul-
monary disease, reduced LVEF or peripheral vascular disease, 
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WHAT IS NEW?
The present analysis confirmed that the occurrence of myocardial infarction with non-obstructive coronary arteries 
(MINOCA) is significantly greater among women compared to men. We showed that sex is not associated with clinical 
outcomes expressed as major cardiac and cerebrovascular events (MACCE) and death in patients with MINOCA during 
almost two years of follow-up. The study also demonstrated that the frequency of recurrent chest pains and rehospi-
talisations during the follow-up period is not significantly related to sex. White blood cell and platelet count, serum 
troponin index, haemoglobin concentration, ST-segment depressions on admission to hospital, age, serum creatinine 
level, hyperlipidaemia, and history of prior venous thromboembolic disease were identified as the predictors of MACCE 
and mortality during follow-up period in patients after MINOCA.
and elevated serum creatinine level, identified a lower level 
of total cholesterol as a predictor, which was also confirmed 
in our study [10]. This finding was named “the cholesterol 
paradox” and it was observed in other populations of patients 
as well [11]. It was also shown that patients who did not 
receive statin therapy before an MINOCA incident and had 
low levels of cholesterol were at increased risk of MACCE 
during follow-up [16]. 
Due to manuscript length limitations we were not able 
to discuss all predictors of MACCE in the follow-up period, 
but attention was also paid to the influence of inflammatory 
markers, such as leucocyte count, and history of venous 
thromboembolism, on MACCE and mortality. The association 
of pro-inflammatory markers with clinical outcomes dur-
ing follow-up is present in a great number of patients with 
myocarditis and other concomitant infectious diseases which 
are definitely more common in the MINOCA group than 
in patients with obstructive CAD. The association between 
clinical outcomes and thromboembolic diseases is undoubt-
edly connected to the fact that most of the MINOCA studies 
include a higher percentage of women, in whom hormonal 
changes are related to reproductive capacity. 
In conclusion, the current analysis confirmed the sig-
nificantly greater occurrence of MINOCA among women 
compared to men. Sex was not associated with worse clinical 
outcomes expressed as MACCE and mortality in patients with 
MINOCA during the follow-up period. The frequency of recur-
rent chest pain and rehospitalisation during follow-up was not 
related to sex either. The following factors can be identified as 
the predictors of MACCE and mortality during the follow-up 
period in patients after MINOCA: leucocyte and platelet 
count, troponin index, blood haemoglobin concentration and 
ST-segment depressions on admission to hospital, age, serum 
creatinine level, and history of venous thromboembolic disease. 
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